Analytics, not advice. Rankings and scores describe past performance and are not recommendations.

Index Fund

Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - IDCW Payout

Tata Mutual Fund · Managed by Rakesh Prajapati; Nitin Sharma

Ask about this fund
FundScore
Latest NAV
₹15.4643
as of 07 Aug 2026
AUM
—
Expense ratio
0.40%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
55/100steady
Rank #559 of 1325 in Index Fund · top 45%

A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.

Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
5.66%
3M
10.50%
6M
27.16%
1Y
18.83%
3Y CAGR
—
5Y CAGR
—
Since incep.
20.72%
Fund details
Fund manager
Rakesh Prajapati; Nitin Sharma
Riskometer
Very High Risk
Type
Open Ended
Portfolio turnover
35%
Volatility (3Y)
16.1%
Rating (external)
—
Investment objective

The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.

NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.

Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.

Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Mid cap64.7%
Small cap35.3%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Jun 2026.
LAURUS LABS LTD
equity
9.36%
LUPIN LTD
equity
9.30%
FORTIS HEALTHCARE LTD
equity
7.90%
AUROBINDO PHARMA LTD
equity
6.99%
GLENMARK PHARMACEUTICALS LTD
equity
5.26%
ALKEM LABORATORIES LTD
equity
5.17%
BIOCON LTD
equity
4.73%
MANKIND PHARMA LTD
equity
4.56%
IPCA LABORATORIES LTD
equity
3.74%
KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD
equity
3.19%
ASTER DM HEALTHCARE LTD
equity
3.15%
GLAND PHARMA LTD
equity
3.15%
J.B.CHEMICALS & PHARMACEUTICALS LTD
equity
2.98%
SAI LIFE SCIENCES LTD
equity
2.69%
WOCKHARDT LTD
equity
2.54%
NEULAND LABORATORIES LTD
equity
2.54%
AJANTA PHARMA LTD
equity
2.28%
NARAYANA HRUDAYALAYA LTD
equity
2.16%
ABBOTT INDIA LTD
equity
2.10%
DR. LAL PATH LABS LTD
equity
2.03%
GRANULES INDIA LTD
equity
1.87%
GLOBAL HEALTH LTD
equity
1.76%
PIRAMAL PHARMA LTD
equity
1.65%
GLAXOSMITHKLINE PHARMACEUTICALS LTD
equity
1.61%
ONESOURCE SPECIALTY PHARMA LTD
equity
1.44%
SYNGENE INTERNATIONAL LTD
equity
1.32%
NATCO PHARMA LTD
equity
1.32%
COHANCE LIFESCIENCES LTD
equity
1.18%
PFIZER LTD
equity
1.07%
POLY MEDICURE LTD
equity
1.02%